Literature DB >> 8926220

Radiotherapy of oral malignant melanomas in dogs.

L Blackwood1, J M Dobson.   

Abstract

OBJECTIVE: To evaluate response to radiotherapy in dogs with oral malignant melanomas.
DESIGN: Clinical trial. ANIMALS: 36 dogs with histologically confirmed oral malignant melanomas. PROCEDURE: The prescribed radiation dose was 36 Gy given in 4 fractions of 9 Gy at 7-day intervals. The primary radiation source was a linear accelerator.
RESULTS: In 25 of 36 dogs, complete remission was achieved, and in 9 dogs, partial remission was achieved. Recurrence of the primary tumor was the cause of euthanasia of 4 dogs. Twenty-one dogs were euthanatized because of metastasis. CLINICAL IMPLICATIONS: Radiotherapy was an effective palliative treatment for the primary tumor in dogs with oral malignant melanomas. However, rapid development of metastatic disease remained a major challenge.

Entities:  

Mesh:

Year:  1996        PMID: 8926220

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  16 in total

1.  Bilateral phalangeal fillet technique for metacarpal pad reconstruction in a dog.

Authors:  Tania Shaw; Fleur James; Lucas Beierer; Giselle Hosgood
Journal:  Can Vet J       Date:  2014-10       Impact factor: 1.008

2.  Exon 15 BRAF mutations are uncommon in canine oral malignant melanomas.

Authors:  Suzanne Shelly; May B Chien; Becky Yip; Michael S Kent; Alain P Theon; Jennifer L McCallan; Cheryl A London
Journal:  Mamm Genome       Date:  2005-03       Impact factor: 2.957

3.  Clinical systemic lupeol administration for canine oral malignant melanoma.

Authors:  Inoru Yokoe; Kazuo Azuma; Keishi Hata; Toshiyuki Mukaiyama; Takahiro Goto; Takeshi Tsuka; Tomohiro Imagawa; Norihiko Itoh; Yusuke Murahata; Tomohiro Osaki; Saburo Minami; Yoshiharu Okamoto
Journal:  Mol Clin Oncol       Date:  2014-10-30

Review 4.  Treatment of Canine Oral Melanomas: A Critical Review of the Literature.

Authors:  Paolo Pazzi; Gerhard Steenkamp; Anouska J Rixon
Journal:  Vet Sci       Date:  2022-04-19

5.  Correlation of pretreatment polarographically measured oxygen pressures with quantified contrast-enhanced power doppler ultrasonography in spontaneous canine tumors and their impact on outcome after radiation therapy.

Authors:  Carla Rohrer Bley; Dagmar Laluhova; Malgorzata Roos; Barbara Kaser-Hotz; Stefanie Ohlerth
Journal:  Strahlenther Onkol       Date:  2009-11-10       Impact factor: 3.621

6.  Potential for BioXmark liquid fiducial marker to improve identification of superficial component of canine oral tumors for computer-based radiation therapy planning.

Authors:  Benoit Clerc-Renaud; Mary-Keara Boss; Lynn R Griffin; Susan M LaRue; Del Leary
Journal:  Can Vet J       Date:  2019-10       Impact factor: 1.008

7.  A retrospective review of outcome and survival following surgery and adjuvant xenogeneic DNA vaccination in 32 dogs with oral malignant melanoma.

Authors:  Elisabetta Treggiari; Jessica Pauline Grant; Susan Margaret North
Journal:  J Vet Med Sci       Date:  2016-01-15       Impact factor: 1.267

8.  Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination.

Authors:  L A Piras; F Riccardo; S Iussich; L Maniscalco; F Gattino; M Martano; E Morello; S Lorda Mayayo; V Rolih; F Garavaglia; R De Maria; E Lardone; F Collivignarelli; D Mignacca; D Giacobino; S Ferrone; F Cavallo; P Buracco
Journal:  Vet Comp Oncol       Date:  2016-05-04       Impact factor: 2.613

9.  Radiation up-regulates the expression of VEGF in a canine oral melanoma cell line.

Authors:  Irene Flickinger; Barbara C Rütgen; Wilhelm Gerner; Ivana Calice; Alexander Tichy; Armin Saalmüller; Miriam Kleiter
Journal:  J Vet Sci       Date:  2013-06-21       Impact factor: 1.672

10.  Evaluation of dog owners' perceptions concerning radiation therapy.

Authors:  Nanna Akerlund Denneberg; Agneta Egenvall
Journal:  Acta Vet Scand       Date:  2009-04-29       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.